腹主动脉瘤腔内修复术后髂支闭塞的荟萃分析与荟萃回归分析
该系统综述纳入13项研究共5454例1995至2014年接受EVAR的患者,采用随机效应模型进行比例荟萃分析。原发性髂支闭塞的合并发生率为5.6%(95%CI 4.0-7.8),近期发表研究中发生率下降(斜率P=0.022)。48%的患者在EVAR后30天内出现闭塞,30天死亡率为0.036(95%CI 0.018-0.070),随访期间死亡率为0.056(95%CI 0.031-0.099),再干预率为0.080(95%CI 0.048-0.130)。作者认为手术比腔内/杂交修复更常用,但证据不足以提示其优越性,未来需研究识别有髂支闭塞风险的患者。
要点
- EVAR术后原发性髂支闭塞合并发生率为5.6%(95%CI 4.0-7.8)。
- 48%(95%CI 41%-56%)的患者在EVAR后30天内出现闭塞。
- 再干预率为0.080(95%CI 0.048-0.130),随访7至39个月。
核心结论
- EVAR术后髂支闭塞发生于5.6%的患者,其中约一半为早期表现。
- 尽管手术治疗更常用,但证据不足以提示其优于腔内/杂交修复。
- 相当数量患者需要再干预,未来需研究识别有髂支闭塞风险的患者。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南,注册方案CRD42017064375。
- 纳入报告EVAR术后髂支闭塞患者的研究,检索电子数据库与参考文献列表。
- 共纳入13项研究,5454例1995至2014年接受EVAR的患者。
- 采用随机效应模型进行比例荟萃分析,并用混合效应回归模型分析发生率随时间变化。
主要发现
- 原发性髂支闭塞的合并发生率为5.6%(95%CI 4.0-7.8)。
- 髂支闭塞发生率在较早研究中更明显,在近期发表研究中下降(斜率P=0.022;Q=5.279)。
- 44%(95%CI 36%-52%)表现为急性,48%(95%CI 41%-56%)在EVAR后30天内出现。
- 17%(95%CI 13%-23%)接受腔内治疗,8%(95%CI 5%-13%)接受杂交手术,61%(95%CI 54%-67%)接受开放手术。
- 30天死亡率为0.036(95%CI 0.018-0.070;异质性P=0.999,I²=0%)。
关键数值与推荐
- 原发性髂支闭塞合并发生率5.6%(95%CI 4.0-7.8)。
- 急性表现44%(95%CI 36%-52%),EVAR后30天内出现48%(95%CI 41%-56%)。
- 腔内治疗17%(95%CI 13%-23%),杂交手术8%(95%CI 5%-13%),开放手术61%(95%CI 54%-67%)。
- 30天死亡率0.036(95%CI 0.018-0.070;I²=0%),随访死亡率0.056(95%CI 0.031-0.099;I²=0%)。
- 再干预率0.080(95%CI 0.048-0.130;I²=0%)。
临床怎么用
- 作者认为尽管手术治疗更常用,但证据不足以提示其优于腔内/杂交修复。
- 作者指出相当数量患者需要再干预。
- 作者提出未来需研究识别有髂支闭塞风险的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our objective was to investigate the incidence, interventions and outcomes of iliac limb occlusion after endovascular aneurysm repair (EVAR). METHODS: We performed a systematic review that conformed to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines using a registered protocol (CRD42017064375). We considered studies reporting patients with iliac limb occlusion after EVAR. We interrogated electronic information sources and bibliographic reference lists using a combination of free text and controlled vocabulary searches. We conducted a proportion meta-analysis of outcomes applying a random effects model. We used mixed effects (methods of moments) regression models to investigate whether the incidence of iliac limb occlusion changed over time. RESULTS: We identified 13 studies reporting a total of 5454 patients who underwent EVAR from 1995 to 2014. The pooled incidence estimate of primary iliac limb occlusion was 5.6% (95% confidence interval [CI], 4.0-7.8). The incidence of iliac limb occlusion was more pronounced in old studies and declined in more recently published studies (slope P = .022; Q=5.279). Forty-four percent (95% CI, 36%-52%) had an acute presentation. One-half of the patients (48%; 95% CI, 41%-56%) presented within 30 days of EVAR. Seventeen percent (95% CI, 13%-23%) underwent endovascular treatment, 8% (95% CI, 5%-13%) received hybrid procedures, and 61% (95% CI, 54%-67%) had open surgery. The 30-day mortality was 0.036 (95% CI, 0.018-0.070; heterogeneity: P = .999, I2 = 0%). The rate of limb loss within 30 days and during follow-up was 0.031 (95% CI, 0.015-0.063; heterogeneity: P = .999; I2 = 0%) and 0.045 (95% CI, 0.024-0.083; heterogeneity: P = .978; I2 = 0%), respectively. Reintervention was undertaken in 0.080 (95% CI, 0.048-0.130; heterogeneity P = .919; I2 = 0%) over a follow-up ranging from 7 to 39 months. The mortality during follow-up was 0.056 (95% CI, 0.031-0.099; heterogeneity: P = .866; I2 = 0%). CONCLUSIONS: Iliac limb occlusion occurred in 5.6% of patients after EVAR. One-half of these patients presented early. Even though surgical treatment has been used more frequently, there is insufficient evidence to suggest its superiority over endovascular/hybrid repair. A considerable number of patients will require reintervention. Future research is needed in identifying patients at risk of iliac limb occlusion.
引用
- Hammond A, Hansrani V, Lowe C, et al. Meta-analysis and meta-regression analysis of iliac limb occlusion after endovascular aneurysm repair. J Vasc Surg. 2018. PMID: 30366653. doi:10.1016/j.jvs.2018.08.153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。